Dr. Tayyaba Ayub, Dr Marvee Sharif, Dr Saleem Akhtar
Close control of blood glucose levels reduces the risk of microvascular and micro fibrillary confusions in patients with type 1 diabetes. In any case, this is troublesome due to the enormous intrasingular fluctuation and other factors that influence blood glucose control. The fundamental limiting factor in achieving severe glucose control in patients on concentrated insulin therapy is the danger of severe hypoglycemia. Thus, hypoglycemia is the major wellness issue in the treatment of type 1 diabetes, influencing the personal satisfaction of patients with this infection. Our current research was conducted at Jinnah Hospital, Lahore from March 2019 to February 2020. Choice aids that rely on AI techniques have achieved a practical approach to improve patient well-being by predicting unfriendly blood glucose functions. This survey proposes the use of four AI calculations to address the issue of well-being in executive diabetes: (1) language advancement for constant medium-term expectation of blood glucose levels, (2) maintenance of vector machines to predict hypoglycemic functions during postprandial periods, (3) false neural organization to predict short-term hypoglycemic scenes, and (4) information extraction to profile diabetes situations at the board level. The proposal includes the blending of standby and order capabilities of the updated approaches. The resulting framework fundamentally reduces the number of hypoglycemic scenes, improving well-being and giving patients greater confidence in the dynamics. Keywords: Planning and prevention of Type 1 diabetes hypoglycemic patients.